Resources from the same session
340O - Radiotherapy is associated with deletion signatures that contribute to poor survival outcomes in cancer patients
Presenter: Emre Kocakavuk
Session: Proffered Paper session - CNS tumours
Resources:
Abstract
Slides
Webcast
341O - A phase 0 ‘Trigger’ trial of CDK4/6 plus ERK1/2 inhibitors in recurrent glioblastoma
Presenter: Nader Sanai
Session: Proffered Paper session - CNS tumours
Resources:
Abstract
Slides
Webcast
342O - Intracranial administration of CTLA-4 and PD-1 immune checkpoint blocking monoclonal antibodies in recurrent glioblastoma (rGB): A multi-cohort adaptive phase I clinical trial
Presenter: Bart Neyns
Session: Proffered Paper session - CNS tumours
Resources:
Abstract
Slides
Webcast
Invited Discussant 340O
Presenter: Monika Hegi
Session: Proffered Paper session - CNS tumours
Resources:
Slides
Webcast
Invited Discussant 341O and 342O
Presenter: Patrick Roth
Session: Proffered Paper session - CNS tumours
Resources:
Slides
Webcast
Q&A and live discussion
Presenter: Patrick Roth
Session: Proffered Paper session - CNS tumours
Resources:
Slides
Webcast